Semaglutiid (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Semaglutiid" in Estonian language version.

refsWebsite

Global rank Estonian rank

8nih.gov

4^th place

14^th place

6doi.org

2^nd place

16^th place

5worldcat.org

5^th place

76^th place

2europa.eu

68^th place

18^th place

1eestiarst.ee

low place

1,098^th place

1drugs.com

399^th place

876^th place

1fda.gov

447^th place

759^th place

1sciencedirect.com

149^th place

130^th place

1wiley.com

222^nd place

147^th place

1uptodate.com

3,771^st place

6,243^rd place

1utlib.ee

low place

90^th place

1mayoclinic.org

1,610^th place

1,426^th place

1nejm.org

2,374^th place

2,360^th place

doi.org

Kalra, Sanjay; Sahay, Rakesh (2020). "A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus". Diabetes Therapy (inglise). 11 (9): 1965–1982. DOI:10.1007/s13300-020-00894-y. ISSN 1869-6961. PMC 7434819. PMID 32725484.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Mahapatra, Manoj Kumar; Karuppasamy, Muthukumar; Sahoo, Biswa Mohan (1. juuni 2022). "Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes". Reviews in Endocrine and Metabolic Disorders (inglise). 23 (3): 521–539. DOI:10.1007/s11154-021-09699-1. ISSN 1573-2606. PMC 8736331. PMID 34993760.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Doyle, Máire E.; Egan, Josephine M. (1. märts 2007). "Mechanisms of action of glucagon-like peptide 1 in the pancreas". Pharmacology & Therapeutics (inglise). 113 (3): 546–593. DOI:10.1016/j.pharmthera.2006.11.007. ISSN 0163-7258.
Hatting, Maximilian; Tavares, Clint D.J.; Sharabi, Kfir; Rines, Amy K.; Puigserver, Pere (2018). "Insulin regulation of gluconeogenesis: Insulin regulation of gluconeogenesis". Annals of the New York Academy of Sciences (inglise). 1411 (1): 21–35. DOI:10.1111/nyas.13435. PMC 5927596. PMID 28868790.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Volke, Vallo (28. september 2021). "Suukaudne semaglutiid". Eesti Arst. DOI:10.15157/ea.vi.18166. ISSN 2228-1665.
Jastreboff, Ania M.; Aronne, Louis J.; Ahmad, Nadia N.; Wharton, Sean; Connery, Lisa; Alves, Breno; Kiyosue, Arihiro; Zhang, Shuyu; Liu, Bing; Bunck, Mathijs C.; Stefanski, Adam (21. juuli 2022). "Tirzepatide Once Weekly for the Treatment of Obesity". New England Journal of Medicine (inglise). 387 (3): 205–216. DOI:10.1056/NEJMoa2206038. ISSN 0028-4793.

drugs.com

"Ozempic (semaglutide) FDA Approval History". Drugs.com (inglise). Vaadatud 15. juunil 2023.

eestiarst.ee

"Semaglutiid – tõhus ravim rasvumise ja ülekaalulisuse korral? - Eesti Arst - Eesti Arstide Liidu ajakiri". eestiarst.ee. Vaadatud 15. juunil 2023.

europa.eu

ema.europa.eu

Euroopa Ravimiamet (EMA). "Ozempic" (PDF). www.ema.europa.eu. Vaadatud 15.06.2023.
Euroopa Ravimiamet (EMA). "Rybelsus" (PDF). ema.europa.eu. Vaadatud 15.06.2023.

fda.gov

Kahn, Jeremy (21. juuni 2021). "FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014". FDA (inglise). Vaadatud 15. juunil 2023.

mayoclinic.org

"Semaglutide (Subcutaneous Route) Side Effects - Mayo Clinic". www.mayoclinic.org. Vaadatud 15. juunil 2023.

nejm.org

Jastreboff, Ania M.; Aronne, Louis J.; Ahmad, Nadia N.; Wharton, Sean; Connery, Lisa; Alves, Breno; Kiyosue, Arihiro; Zhang, Shuyu; Liu, Bing; Bunck, Mathijs C.; Stefanski, Adam (21. juuli 2022). "Tirzepatide Once Weekly for the Treatment of Obesity". New England Journal of Medicine (inglise). 387 (3): 205–216. DOI:10.1056/NEJMoa2206038. ISSN 0028-4793.

nih.gov

ncbi.nlm.nih.gov

Kalra, Sanjay; Sahay, Rakesh (2020). "A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus". Diabetes Therapy (inglise). 11 (9): 1965–1982. DOI:10.1007/s13300-020-00894-y. ISSN 1869-6961. PMC 7434819. PMID 32725484.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Mahapatra, Manoj Kumar; Karuppasamy, Muthukumar; Sahoo, Biswa Mohan (1. juuni 2022). "Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes". Reviews in Endocrine and Metabolic Disorders (inglise). 23 (3): 521–539. DOI:10.1007/s11154-021-09699-1. ISSN 1573-2606. PMC 8736331. PMID 34993760.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Hatting, Maximilian; Tavares, Clint D.J.; Sharabi, Kfir; Rines, Amy K.; Puigserver, Pere (2018). "Insulin regulation of gluconeogenesis: Insulin regulation of gluconeogenesis". Annals of the New York Academy of Sciences (inglise). 1411 (1): 21–35. DOI:10.1111/nyas.13435. PMC 5927596. PMID 28868790.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Farzam, Khashayar; Patel, Preeti (2023), "Tirzepatide", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 36251836, vaadatud 15. juunil 2023

pubmed.ncbi.nlm.nih.gov

Kalra, Sanjay; Sahay, Rakesh (2020). "A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus". Diabetes Therapy (inglise). 11 (9): 1965–1982. DOI:10.1007/s13300-020-00894-y. ISSN 1869-6961. PMC 7434819. PMID 32725484.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Mahapatra, Manoj Kumar; Karuppasamy, Muthukumar; Sahoo, Biswa Mohan (1. juuni 2022). "Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes". Reviews in Endocrine and Metabolic Disorders (inglise). 23 (3): 521–539. DOI:10.1007/s11154-021-09699-1. ISSN 1573-2606. PMC 8736331. PMID 34993760.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Hatting, Maximilian; Tavares, Clint D.J.; Sharabi, Kfir; Rines, Amy K.; Puigserver, Pere (2018). "Insulin regulation of gluconeogenesis: Insulin regulation of gluconeogenesis". Annals of the New York Academy of Sciences (inglise). 1411 (1): 21–35. DOI:10.1111/nyas.13435. PMC 5927596. PMID 28868790.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Farzam, Khashayar; Patel, Preeti (2023), "Tirzepatide", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 36251836, vaadatud 15. juunil 2023

sciencedirect.com

Doyle, Máire E.; Egan, Josephine M. (1. märts 2007). "Mechanisms of action of glucagon-like peptide 1 in the pancreas". Pharmacology & Therapeutics (inglise). 113 (3): 546–593. DOI:10.1016/j.pharmthera.2006.11.007. ISSN 0163-7258.

uptodate.com

Dungan, Kathleen; DeSantis, Anthony (4. mai 2023). "Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus". www.uptodate.com. Vaadatud 15. juunil 2023.

utlib.ee

ojs.utlib.ee

Volke, Vallo (28. september 2021). "Suukaudne semaglutiid". Eesti Arst. DOI:10.15157/ea.vi.18166. ISSN 2228-1665.

wiley.com

onlinelibrary.wiley.com

Hatting, Maximilian; Tavares, Clint D.J.; Sharabi, Kfir; Rines, Amy K.; Puigserver, Pere (2018). "Insulin regulation of gluconeogenesis: Insulin regulation of gluconeogenesis". Annals of the New York Academy of Sciences (inglise). 1411 (1): 21–35. DOI:10.1111/nyas.13435. PMC 5927596. PMID 28868790.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)

worldcat.org

Kalra, Sanjay; Sahay, Rakesh (2020). "A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus". Diabetes Therapy (inglise). 11 (9): 1965–1982. DOI:10.1007/s13300-020-00894-y. ISSN 1869-6961. PMC 7434819. PMID 32725484.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Mahapatra, Manoj Kumar; Karuppasamy, Muthukumar; Sahoo, Biswa Mohan (1. juuni 2022). "Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes". Reviews in Endocrine and Metabolic Disorders (inglise). 23 (3): 521–539. DOI:10.1007/s11154-021-09699-1. ISSN 1573-2606. PMC 8736331. PMID 34993760.{{ajakirjaviide}}: CS1 hooldus: PMC vormistus (link)
Doyle, Máire E.; Egan, Josephine M. (1. märts 2007). "Mechanisms of action of glucagon-like peptide 1 in the pancreas". Pharmacology & Therapeutics (inglise). 113 (3): 546–593. DOI:10.1016/j.pharmthera.2006.11.007. ISSN 0163-7258.
Volke, Vallo (28. september 2021). "Suukaudne semaglutiid". Eesti Arst. DOI:10.15157/ea.vi.18166. ISSN 2228-1665.
Jastreboff, Ania M.; Aronne, Louis J.; Ahmad, Nadia N.; Wharton, Sean; Connery, Lisa; Alves, Breno; Kiyosue, Arihiro; Zhang, Shuyu; Liu, Bing; Bunck, Mathijs C.; Stefanski, Adam (21. juuli 2022). "Tirzepatide Once Weekly for the Treatment of Obesity". New England Journal of Medicine (inglise). 387 (3): 205–216. DOI:10.1056/NEJMoa2206038. ISSN 0028-4793.